| Jul 16 2025 |
Shielding Reproductive Freedom: Uncovering New York’s Law Protecting Providers from Civil and Criminal Liability |
Epstein Becker & Green, P.C. |
| Jul 16 2025 |
Sport On Steroids: Walking the Ethical and Legal Tightrope of the Enhanced Games |
Squire Patton Boggs (US) LLP |
| Jul 15 2025 |
PANNA Files Writ of Mandamus against EPA for Failing to Respond to Petition to Cancel Organophosphate Pesticides |
Bergeson & Campbell, P.C. |
| Jul 15 2025 |
Navigating FDA’s Proposed Guidance on AI and Non-Animal Models: Safeguarding Innovation in Drug Development |
Foley & Lardner LLP |
| Jul 15 2025 |
Consumer Compass Newsletter- July 2025 |
Greenberg Traurig, LLP |
| Jul 15 2025 |
Is Your Enantiomer Possessed? Patenting of Enantiomers – Does Written Description Require More Than Actual Possession? |
Mintz |
| Jul 15 2025 |
Device Patents in the Orange Book: May 21, 2025, FTC Warning Letters Appear to have Minimal Impact |
Polsinelli PC |
| Jul 14 2025 |
Latest Moves by Federal Agencies Regarding Gender-Affirming Care: Risks Mount for Providers |
Epstein Becker & Green, P.C. |
| Jul 14 2025 |
How Much Plastic is Too Much? Class Action Plaintiffs Skip the Homework and Fail the Test |
Hunton Andrews Kurth |
| Jul 14 2025 |
FDA: Commissioner’s National Priority Voucher Program Aims to Streamline Some Drug Reviews |
Foley & Lardner LLP |
| Jul 12 2025 |
White House OSTP Issues Agency Guidance for Gold Standard Science |
Bergeson & Campbell, P.C. |
| Jul 11 2025 |
McDermott+ Check-Up – July 11, 2025 |
McDermott Will & Schulte LLP |
| Jul 11 2025 |
DOJ Issues Subpoenas Targeting Transgender Care to Minors: What Health Care Providers Need to Know |
Mintz |
| Jul 11 2025 |
China on the Move: China’s Healthcare and Life Sciences Regulatory Evolution in 2025 |
Greenberg Traurig, LLP |
| Jul 10 2025 |
North Carolina Governor Forms a [High] Council on Cannabis |
Bradley Arant Boult Cummings LLP |
| Jul 10 2025 |
OECD Publishes Case Study on 2D Titanium Carbide MXenes |
Bergeson & Campbell, P.C. |
| Jul 10 2025 |
FDA in Flux — July 2025 Newsletter |
Mintz |
| Jul 9 2025 |
FDA Official Says FDA Plans to Issue Guidance as Normal Despite “10-1 Executive Order” |
Keller and Heckman LLP |
| Jul 9 2025 |
This Week in 340B: July 1 – 7, 2025 |
McDermott Will & Schulte LLP |
| Jul 9 2025 |
New Louisiana Law Mandates Ingredient Disclosures & Bans Ingredients in Schools |
Keller and Heckman LLP |
| Jul 9 2025 |
Patenting AI: Proliferation of AI Technologies Across Diverse Industry Sectors |
ArentFox Schiff LLP |
| Jul 9 2025 |
European Union Releases Plans to Help Boost Novel Food Applications |
Keller and Heckman LLP |
| Jul 9 2025 |
Health Law Diagnosed – Best Practices for Communicating with the FDA [Podcast] |
Mintz |
| Jul 9 2025 |
FDA Begins Public Comment Period on Method for Ranking Chemicals in Food for Post-Market Assessments |
Bergeson & Campbell, P.C. |
| Jul 8 2025 |
Today in Needlessly Cruel and Silly News: Alabama Hemp Law Soon to End Availability of Popular CBD Products to Pets |
Bradley Arant Boult Cummings LLP |
| Jul 8 2025 |
Federal Court Temporarily Halts Iowa’s PBM Reform Law Amid Legal Challenges |
Mintz |
| Jul 8 2025 |
APHIS Seeks Comment on Draft Environmental Documents for Deregulation of American Chestnut Developed Using Genetic Engineering |
Bergeson & Campbell, P.C. |
| Jul 8 2025 |
The Dangers of Utilizing Compliance Consultants When Responding to an Audit |
MDRX Law - Sauchik & Giyaur, P.C. |
| Jul 7 2025 |
Healthcare Preview for the Week of: July 7, 2025 [Podcast] |
McDermott Will & Schulte LLP |
| Jul 7 2025 |
Texas Enacts Sweeping Food Additive Labeling Law: Implications for the Industry and Interstate Commerce |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 7 2025 |
APHIS Amends Regulations to Conform to Vacatur of SECURE Rule |
Bergeson & Campbell, P.C. |
| Jul 3 2025 |
FDA Publishes Proposed 2025 Human Foods Program Guidance Agenda |
Keller and Heckman LLP |
| Jul 3 2025 |
Texas Becomes Seventh State to Ban Lab-Grown Meat |
Keller and Heckman LLP |
| Jul 3 2025 |
FinCEN’s Groundbreaking 2313a Orders: What U.S. Banks Need to Know About the Crackdown on Mexican Cartel-Linked Financial Institutions |
Bradley Arant Boult Cummings LLP |
| Jul 3 2025 |
CODEX ALIMENTARIUS: Main Outcome of the 34th Committee on General Principles (CCGP34) |
Keller and Heckman LLP |
